Immunic (IMUX) Interest & Investment Income (2013 - 2026)
Immunic's (IMUX) quarterly Interest & Investment Income came in at $760000.0 in Q1 2026, up 315.3% year-on-year from $183000.0 in Q1 2025, and up 285.79% quarter-over-quarter from $197000.0 in Q4 2025.
Immunic (IMUX) Interest & Investment Income (2013 - 2026) Analysis & Trends
Immunic has disclosed Interest & Investment Income across 14 years of filings, most recently posting $760000.0 for Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $760000.0, up 315.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (down 32.23% YoY), and the FY2025 annual result was $1.0 million, down 69.32% from the prior year.
- Interest & Investment Income came in at $760000.0 for Q1 2026 at Immunic, up from $197000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.2 million in Q1 2024 to a low of $7000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $541000.0 (2023), against an average of $547411.8.
- Across the five-year window, Interest & Investment Income surged 11328.57% in 2023 and tumbled 84.58% in 2025, its largest moves.
- Immunic's Interest & Investment Income stood at $698000.0 in 2022, then retreated by 22.49% to $541000.0 in 2023, then decreased by 20.7% to $429000.0 in 2024, then tumbled by 54.08% to $197000.0 in 2025, then surged by 285.79% to $760000.0 in 2026.
- The last three Interest & Investment Income figures came in at $760000.0 (Q1 2026), $197000.0 (Q4 2025), and $419000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 597,319.59 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -14.79 Mn |
| 10 | Immunic | 384.84 Mn | 198.21 Mn | - | 760,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 760,000.00 |
| Dec 31, 2025 | 197,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Jun 30, 2025 | 241,000.00 |
| Mar 31, 2025 | 183,000.00 |
| Dec 31, 2024 | 429,000.00 |
| Sep 30, 2024 | 776,000.00 |
| Jun 30, 2024 | 998,000.00 |
| Mar 31, 2024 | 1.19 Mn |
| Dec 31, 2023 | 541,000.00 |
| Sep 30, 2023 | 766,000.00 |
| Jun 30, 2023 | 968,000.00 |
| Mar 31, 2023 | 800,000.00 |
| Dec 31, 2022 | 698,000.00 |
| Sep 30, 2022 | 230,000.00 |
| Jun 30, 2022 | 106,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 15,000.00 |
| Sep 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 13,000.00 |